These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 30976063)

  • 1. Specific protein 1(SP1) regulates the epithelial-mesenchymal transition via lysyl oxidase-like 2(LOXL2) in pancreatic ductal adenocarcinoma.
    Kim IK; Lee YS; Kim HS; Dong SM; Park JS; Yoon DS
    Sci Rep; 2019 Apr; 9(1):5933. PubMed ID: 30976063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging role of LOXL2 in the promotion of pancreas cancer metastasis.
    Park JS; Lee JH; Lee YS; Kim JK; Dong SM; Yoon DS
    Oncotarget; 2016 Jul; 7(27):42539-42552. PubMed ID: 27285767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Implications of Lysyl Oxidase-Like Protein 2 Expression in Pancreatic Cancer.
    Tanaka N; Yamada S; Sonohara F; Suenaga M; Hayashi M; Takami H; Niwa Y; Hattori N; Iwata N; Kanda M; Tanaka C; Kobayashi D; Nakayama G; Koike M; Fujiwara M; Fujii T; Kodera Y
    Sci Rep; 2018 Jun; 8(1):9846. PubMed ID: 29959362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of FOXO3a induces epithelial-mesenchymal transition and promotes metastasis of pancreatic ductal adenocarcinoma by activation of the β-catenin/TCF4 pathway through SPRY2.
    Li J; Yang R; Dong Y; Chen M; Wang Y; Wang G
    J Exp Clin Cancer Res; 2019 Jan; 38(1):38. PubMed ID: 30691517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deciphering the TCF19/miR-199a-5p/SP1/LOXL2 pathway: Implications for breast cancer metastasis and epithelial-mesenchymal transition.
    Li SY; Zhang N; Zhang H; Wang N; Du YY; Li HN; Huang CS; Li XR
    Cancer Lett; 2024 Aug; 597():216995. PubMed ID: 38851313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neural Wiskott-Aldrich syndrome protein (N-WASP) promotes distant metastasis in pancreatic ductal adenocarcinoma via activation of LOXL2.
    Kim HS; Lee YS; Dong SM; Kim HJ; Lee DE; Kang HW; Kim MJ; Park JS
    Oncol Res; 2024; 32(4):615-624. PubMed ID: 38560567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
    Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
    J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencing of lysyl oxidase‑like 2 inhibits the migration, invasion and epithelial‑to‑mesenchymal transition of renal cell carcinoma cells through the Src/FAK signaling pathway.
    Hong X; Yu JJ
    Int J Oncol; 2019 May; 54(5):1676-1690. PubMed ID: 30816490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
    Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
    World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional analysis of LOXL2 in pancreatic carcinoma.
    Rückert F; Joensson P; Saeger HD; Grützmann R; Pilarsky C
    Int J Colorectal Dis; 2010 Mar; 25(3):303-11. PubMed ID: 20012301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous high expression of PLD1 and Sp1 predicts a poor prognosis for pancreatic ductal adenocarcinoma patients.
    Hu J; Hu H; Hang JJ; Yang HY; Wang ZY; Wang L; Chen DH; Wang LW
    Oncotarget; 2016 Nov; 7(48):78557-78565. PubMed ID: 27713167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Escin Ia suppresses the metastasis of triple-negative breast cancer by inhibiting epithelial-mesenchymal transition via down-regulating LOXL2 expression.
    Wang Y; Xu X; Zhao P; Tong B; Wei Z; Dai Y
    Oncotarget; 2016 Apr; 7(17):23684-99. PubMed ID: 27008697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LOXL2 expression is associated with invasiveness and negatively influences survival in breast cancer patients.
    Ahn SG; Dong SM; Oshima A; Kim WH; Lee HM; Lee SA; Kwon SH; Lee JH; Lee JM; Jeong J; Lee HD; Green JE
    Breast Cancer Res Treat; 2013 Aug; 141(1):89-99. PubMed ID: 23933800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysyl oxidase-like 2 as a new poor prognosis marker of squamous cell carcinomas.
    Peinado H; Moreno-Bueno G; Hardisson D; Pérez-Gómez E; Santos V; Mendiola M; de Diego JI; Nistal M; Quintanilla M; Portillo F; Cano A
    Cancer Res; 2008 Jun; 68(12):4541-50. PubMed ID: 18559498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulated long noncoding RNA LINC01296 indicates a dismal prognosis for pancreatic ductal adenocarcinoma and promotes cell metastatic properties by affecting EMT.
    Yuan Q; Zhang Y; Feng L; Jiang Y
    J Cell Biochem; 2019 Jan; 120(1):552-561. PubMed ID: 30203487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta Type II receptor expression in human pancreatic cancer cells.
    Zhao S; Venkatasubbarao K; Li S; Freeman JW
    Cancer Res; 2003 May; 63(10):2624-30. PubMed ID: 12750289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and characterization of the promoter of cancer-related gene LOXL2.
    Liu X; Liu T; Hu L; Jiang T; Liu H; Wang Y; Lei Y; Zhu J; Bu Y
    Exp Cell Res; 2020 Feb; 387(2):111786. PubMed ID: 31870772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophages direct cancer cells through a LOXL2-mediated metastatic cascade in pancreatic ductal adenocarcinoma.
    Alonso-Nocelo M; Ruiz-Cañas L; Sancho P; Görgülü K; Alcalá S; Pedrero C; Vallespinos M; López-Gil JC; Ochando M; García-García E; David Trabulo SM; Martinelli P; Sánchez-Tomero P; Sánchez-Palomo C; Gonzalez-Santamaría P; Yuste L; Wörmann SM; Kabacaoğlu D; Earl J; Martin A; Salvador F; Valle S; Martin-Hijano L; Carrato A; Erkan M; García-Bermejo L; Hermann PC; Algül H; Moreno-Bueno G; Heeschen C; Portillo F; Cano A; Sainz B
    Gut; 2023 Feb; 72(2):345-359. PubMed ID: 35428659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Stat3/Nrf2 pathway in pancreatic cancer cells.
    Wu YS; Chung I; Wong WF; Masamune A; Sim MS; Looi CY
    Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):296-306. PubMed ID: 27750041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-29a Is Repressed by MYC in Pancreatic Cancer and Its Restoration Drives Tumor-Suppressive Effects via Downregulation of LOXL2.
    Dey S; Kwon JJ; Liu S; Hodge GA; Taleb S; Zimmers TA; Wan J; Kota J
    Mol Cancer Res; 2020 Feb; 18(2):311-323. PubMed ID: 31662451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.